Orphan status granted for AZ's thyroid cancer drug

11/1/2005 | Reuters

The FDA has granted orphan drug status for AstraZeneca's Zactima for treatment of patients with rare forms of thyroid cancer. The drug also is being evaluated as a treatment for lung cancer, with final Phase III tests due to begin in the next few months.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID